STRS Ohio’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

STRS Ohio’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-46,300	Closed	-$187K	–	2059
2023 Q4	$187K	Buy	46,300 +43,600	+1,615%	+$133K	﹤0.01%	1582
2023 Q3	$7K	Hold	2,700	–	–	﹤0.01%	1914
2023 Q2	$25K	Hold	2,700	–	–	﹤0.01%	1871
2023 Q1	$23K	Hold	2,700	–	–	﹤0.01%	1859
2022 Q4	$13K	Hold	2,700	–	–	﹤0.01%	1912
2022 Q3	$15K	Hold	2,700	–	–	﹤0.01%	1947
2022 Q2	$14K	Hold	2,700	–	–	﹤0.01%	1980
2022 Q1	$31K	Hold	2,700	–	–	﹤0.01%	2005
2021 Q4	$34K	Buy	+2,700	New	+$40.8K	﹤0.01%	2057

STRS Ohio's THRX Position: Q1 2024 in Review

STRS Ohio sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 46,300 shares — an estimated $187K sold.

STRS Ohio first reported a position in THRX in Q4 2021 and held it in 9 quarters. The position peaked at $187K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

STRS Ohio reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
STRS Ohio sold 46,300 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $187K.
STRS Ohio first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
STRS Ohio's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $187K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on STRS Ohio's 13F filing for Q1 2024, filed 13 May 2024.